Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines and inflammatory bowel disease.

A C Anand1, C M Adya

  • 1Command Hospital (WC), Chandimandir.

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|March 1, 2000
PubMed
Summary

Cytokines are key to inflammatory bowel disease (IBD) treatment. New strategies targeting cytokines show promise, but understanding their precise mechanisms and improving clinical trial designs are crucial for effective IBD therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indian National Association for the Study of the Liver Position Statements on Prevention, Diagnosis, and Management of Hepatitis B Virus Infection in India.

Journal of clinical and experimental hepatology·2025
Same author

Gastrointestinal: Anticoagulant-induced intramural duodenal hematoma presenting as gastric outlet obstruction.

Journal of gastroenterology and hepatology·2020
Same author

Indian healthcare at crossroads (part 3): Quo vadis?

The National medical journal of India·2020
Same author

Gastrointestinal: An unusual cause of lower gastrointestinal bleed: Ileal carcinoid tumor.

Journal of gastroenterology and hepatology·2019
Same author

Medical Practice Management: An update.

The National medical journal of India·2017
Same author

SILENT GALLSTONES: TO DO OR NOT TO DO?

Medical journal, Armed Forces India·2017

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • Cytokines are central mediators of inflammation in inflammatory bowel disease (IBD).
  • Current therapeutic strategies for IBD are increasingly focusing on cytokine modulation.
  • Significant knowledge gaps persist regarding the precise mechanisms of action for cytokine-targeted therapies.

Purpose of the Study:

  • To review the current understanding of cytokine roles in IBD.
  • To identify challenges and opportunities in developing novel IBD therapeutic strategies.
  • To critically assess the validity of pre-clinical models and clinical trial designs for IBD therapies.

Main Methods:

  • Review of existing literature on cytokine-based therapies for IBD.
  • Analysis of clinical trial outcomes for specific cytokine inhibitors and modulators.
  • Discussion of emerging therapeutic approaches, including monoclonal antibodies and cytokine administration.

Main Results:

  • The efficacy of anti-tumor necrosis factor (TNF)-alpha antibodies requires further elucidation regarding their mechanism (e.g., simple clearance vs. cell surface binding).
  • Clinical trial results for interleukin (IL)-10 have been disappointing, questioning the predictive validity of animal models and trial designs.
  • Novel approaches include targeting effector T cell molecules, cytokine-secreting cell removal, and utilizing anti-inflammatory cytokines.

Conclusions:

  • Developing effective IBD therapies necessitates a deeper understanding of cytokine functions and therapeutic mechanisms.
  • Improving the definition of clinical endpoints and assessing biological efficacy are critical for advancing IBD treatment.
  • Comprehensive management of IBD requires further research into genetic factors and environmental triggers.

Related Experiment Videos